Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 31.71M
March 31, 2026 22.73M
December 31, 2025 22.78M
September 30, 2025 57.94M
June 30, 2025 56.59M
March 31, 2025 60.75M
December 31, 2024 64.48M
September 30, 2024 66.98M
June 30, 2024 65.31M
March 31, 2024 64.80M
December 31, 2023 61.83M
September 30, 2023 54.84M
June 30, 2023 6.801M
March 31, 2023 3.793M
December 31, 2022 4.688M
September 30, 2022 4.382M
June 30, 2022 47.10M
March 31, 2022 46.20M
Date Value
December 31, 2021 47.52M
September 30, 2021 47.90M
June 30, 2021 46.87M
March 31, 2021 46.29M
December 31, 2020 41.17M
September 30, 2020 40.75M
June 30, 2020 38.77M
March 31, 2020 37.83M
December 31, 2019 3.409M
September 30, 2019 4.421M
June 30, 2019 4.405M
March 31, 2019 3.218M
December 31, 2018 2.477M
September 30, 2018 2.451M
June 30, 2018 3.125M
March 31, 2018 1.648M
December 31, 2017 0.616M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 896.90M
Corcept Therapeutics, Inc. 182.93M
Veru, Inc. 8.651M
Johnson & Johnson 116.09B
Eli Lilly & Co. 108.40B

Total Liabilities (Quarterly) Related Metrics